These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1949940)

  • 21. Antibody to endotoxin in the treatment of gram-negative sepsis.
    van Deventer S
    JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monoclonal antibodies in the treatment of sepsis caused by Gram-negative microorganisms].
    Otero AJ; Linares M
    Rev Cubana Med Trop; 1998; 50(1):31-5. PubMed ID: 9842265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody to endotoxin in the treatment of gram-negative sepsis.
    Schentag JJ
    JAMA; 1992 May; 267(17):2326-7. PubMed ID: 1564766
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody to endotoxin in the treatment of gram-negative sepsis.
    Spalter J
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564764
    [No Abstract]   [Full Text] [Related]  

  • 25. Life-saving immunotherapy with cross-reactive monoclonal antibodies against endotoxin: a critical evaluation of experimental and clinical studies.
    Cornelissen JJ; Schellekens JF; Kraaijeveld CA; Verhoef J
    Neth J Med; 1991 Oct; 39(3-4):170-6. PubMed ID: 1791879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.
    Behre G; Schedel I; Nentwig B; Wörmann B; Essink M; Hiddemann W
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2139-46. PubMed ID: 1444293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of monoclonal antibody therapy in the treatment of infectious disease.
    Chmel H
    Am J Hosp Pharm; 1990 Nov; 47(11 Suppl 3):S11-5. PubMed ID: 2275476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes.
    Seelen MA; Athanassiou P; Lynn WA; Norsworthy P; Walport MJ; Cohen J; Davies KA
    Immunology; 1995 Apr; 84(4):653-61. PubMed ID: 7790040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.
    Spapen HD; Diltoer M; Huyghens LP
    Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human monoclonal antibody against endotoxin.
    Zarowitz BJ
    DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effects of E5, an antiendotoxin monoclonal antibody, in the ovine pulmonary circulation.
    Chen TY; Zapol WM; Greene E; Robinson DR; Rubin RH
    J Appl Physiol (1985); 1993 Jul; 75(1):233-9. PubMed ID: 8376269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of endotoxemia and septicemia.
    Baumgartner JD; Glauser MP
    Immunobiology; 1993 Apr; 187(3-5):464-77. PubMed ID: 8330909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides.
    Wood DM; Parent JB; Gazzano-Santoro H; Lim E; Pruyne PT; Watkins JM; Spoor ES; Reardan DT; Trown PW; Conlon PJ
    Circ Shock; 1992 Sep; 38(1):55-62. PubMed ID: 1394865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis.
    Albertson TE; Panacek EA; MacArthur RD; Johnson SB; Benjamin E; Matuschak GM; Zaloga G; Maki D; Silverstein J; Tobias JK; Haenftling K; Black G; Cowens JW;
    Crit Care Med; 2003 Feb; 31(2):419-27. PubMed ID: 12576946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW; Lee TH
    Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Baumgartner JD
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):711-6. PubMed ID: 2261915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study of anti-lipopolysaccharide human monoclonal antibody MAB-T88 in patients with gram-negative sepsis.
    Daifuku R; Panacek EA; Haenftling K; Swenson WK; Prescott AW; Johnson JL
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):36-9. PubMed ID: 8431557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal anti-lipid A IgM antibodies HA-1A and E-5 recognize distinct epitopes on lipopolysaccharide and lipid A.
    Fujihara Y; Bogard WC; Lei MG; Daddona PE; Morrison DC
    J Infect Dis; 1993 Dec; 168(6):1429-35. PubMed ID: 7504034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide.
    Priest BP; Brinson DN; Schroeder DA; Dunn DL
    Surgery; 1989 Aug; 106(2):147-54; discussion 154-5. PubMed ID: 2763023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.